Leaflet PREVENAR 13 CONJUGATED SACCHARIDE PNEUMOCOCCAL VACCINE (13-VALENT ADSORBED) suspension for injection in pre-filled syringe
Indicated for: prevention of pneumococcal disease
Route of administration: injectable
Substance: polysaccharide conjugate pneumococcal vaccine (vaccine)
ATC: J07AL02 (Antiinfectives for systemic use | Bacterial vaccines | Pneumococcal vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The pneumococcal conjugate vaccine (PCV13) is used to prevent infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, and otitis media. The vaccine contains capsular polysaccharides from 13 different serotypes of the bacterium, linked to a carrier protein, which stimulates a stronger and longer-lasting immune response.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for children, adults, and individuals at increased risk of pneumococcal infections.
Common side effects include pain at the injection site, mild fever, irritability, and fatigue. In rare cases, severe allergic reactions may occur.
The pneumococcal conjugate vaccine is an essential measure for protecting against pneumococcal infections, particularly among young children and vulnerable individuals, helping to reduce the morbidity and mortality associated with these infections.
General data about PREVENAR 13 CONJUGATED SACCHARIDE PNEUMOCOCCAL VACCINE (13-VALENT ADSORBED)
- Substance: polysaccharide conjugate pneumococcal vaccine
- Date of latest medicines list: 01-09-2016
- Product code: W60168002
- Pharmaceutical form: suspension for injection in pre-filled syringe
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.